Copyright © 2000 by the European Society of Cardiology.
Microalbuminuria is independently associated with ischaemic electrocardiographic abnormalities in a large non-diabetic population. The PREVEND (Prevention of REnal and Vascular ENdstage Disease) study
a Department of Clinical Pharmacology, University of Groningen, Groningen, The Netherlands
b Department of Cardiology, Academic Hospital, Groningen, The Netherlands
c Department of Nephrology, Academic Hospital, Groningen, The Netherlands
d Department of Medical Informatics, Erasmus University, Rotterdam, The Netherlands
e Julius Center for Patient Oriented Research, University Medical Center, Utrecht, The Netherlands
Received April 11, 2000; accepted April 12, 2000
Abstract
Aim To assess the value of microalbuminuria as an indicator of increased cardiovascular risk in a non-diabetic population.
Methods and Results 7579 non-diabetic subjects were studied with ages ranging from 28 to 75 years selected from a population based cohort. Using computerized Minnesota coding, ischaemic electrocardiographic abnormalities were divided into three categories: infarct patterns, major ischaemia, and minor ischaemia. Urinary albumin excretion was measured as the mean of two 24-h urine collections. Cardiovascular risk indicators were defined as an age above 60 years, male sex, hypertension, hypercholesterolaemia, smoking, obesity and a positive cardiovascular family history. Microalbuminuria was associated with age, sex, blood pressure, serum cholesterol, serum glucose, body mass index and all three categories of electrocardiographic abnormalities. In a multivariate model, adjusted for established cardiovascular risk indicators, microalbuminuria was independently associated with infarct patterns (OR [95% CI] 1·61 [1·12–2·32]), major ischaemia (OR 1·43 [1·08–1·91]) and minor ischaemia (OR 1·32 [1·03–1·68]).
Conclusions The independent association between microalbuminuria and ischaemic electrocardiographic abnormalities suggests that microalbuminuria has additional value to conventional risk indicators in predicting cardiovascular disease in non-diabetics. Assessment of microalbuminuria could be an instrument to identify those at an increased risk for coronary vascular disease in an early stage.
Key Words: Microalbuminuria, electrocardiography, coronary heart disease, non-diabetic
f1 Correspondence: G. F. H. Diercks, MD, Department of Clinical Pharmacology, University of Groningen, A. Deusinglaan 1, 9713 AV Groningen, The Netherlands.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  M. E. Suliman, M. I. Yilmaz, J. J. Carrero, A. R. Qureshi, M. Saglam, O. M. Ipcioglu, M. Yenicesu, M. Tong, O. Heimburger, P. Barany, et al. Novel Links between the Long Pentraxin 3, Endothelial Dysfunction, and Albuminuria in Early and Advanced Chronic Kidney Disease Clin. J. Am. Soc. Nephrol., July 1, 2008; 3(4): 976 - 985. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. R. Weir Microalbuminuria and Cardiovascular Disease Clin. J. Am. Soc. Nephrol., May 1, 2007; 2(3): 581 - 590. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Sonmez, A. O. Eskisar, D. Demir, M. V. Yazicioglu, B. Mutlu, Y. Dogan, A. Izgi, D. Mansuroglu, R. B. Bakal, O. H. Elonu, et al. Increased Urinary Albumin Excretion Rates Can Be a Marker of Coexisting Coronary Artery Disease in Patients with Peripheral Arterial Disease Angiology, January 1, 2006; 57(1): 15 - 20. [Abstract] [PDF]
|
|
|
|
 |
|
 M. Cirillo, M. Laurenzi, M. Mancini, A. Zanchetti, and N. G. De Santo Low Muscular Mass and Overestimation of Microalbuminuria by Urinary Albumin/Creatinine Ratio Hypertension, January 1, 2006; 47(1): 56 - 61. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Montalescot and J.-P. Collet Preserving cardiac function in the hypertensive patient: why renal parameters hold the key Eur. Heart J., December 2, 2005; 26(24): 2616 - 2622. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E V Barnes, S Narain, A Naranjo, J Shuster, M S Segal, E S Sobel, A E Armstrong, B E Santiago, W H Reeves, and H B Richards High sensitivity C-reactive protein in systemic lupus erythematosus: relation to disease activity, clinical presentation and implications for cardiovascular risk Lupus, August 1, 2005; 14(8): 576 - 582. [Abstract] [PDF]
|
|
|
|
 |
|
 R. Pontremoli, G. Leoncini, M. Ravera, F. Viazzi, S. Vettoretti, E. Ratto, D. Parodi, C. Tomolillo, and G. Deferrari Microalbuminuria, Cardiovascular, and Renal Risk in Primary Hypertension J. Am. Soc. Nephrol., November 1, 2002; 13(90003): S169 - 172. [Abstract] [Full Text]
|
|
|
|
 |
|
 G. F. H. Diercks, H. L. Hillege, A. d J. van Boven, J. A. Kors, H. J. G. M. Crijns, D. E. Grobbee, P. E. de Jong, and W. H. van Gilst Microalbuminuria modifies the mortality risk associated with electrocardiographic ST-T segment changes J. Am. Coll. Cardiol., October 16, 2002; 40(8): 1401 - 1407. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Pedrinelli, G. Dell'Omo, G. Penno, and M. Mariani Non-diabetic microalbuminuria, endothelial dysfunction and cardiovascular disease Vascular Medicine, November 1, 2001; 6(4): 257 - 264. [Abstract] [PDF]
|
|
|
|
|
|
G.C. Viberti and S.M. Thomas Searching for new coronary heart disease risk factors Eur. Heart J., December 1, 2000; 21(23): 1905 - 1906. [PDF]
|
|